XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net income $ 507.6 $ 568.0
Reconciliation to cash provided by operating activities    
Depreciation and amortization 305.5 278.1
Deferred income taxes and ITCs, net 56.5 103.8
Contributions and payments related to pension and OPEB plans (5.5) (3.6)
Equity income in transmission affiliates, net of distributions (6.4) (7.7)
Change in –    
Accounts receivable and unbilled revenues, net 60.7 (174.3)
Materials, supplies, and inventories 293.6 267.0
Prepaid taxes 48.8 62.5
Collateral on deposit (91.8) 0.2
Other current assets 40.6 21.3
Accounts payable (424.7) (293.8)
Temporary LIFO liquidation credit 43.8 130.7
Collateral received 0.0 132.5
Other current liabilities 19.9 26.3
Other, net (52.5) (34.2)
Net cash provided by operating activities 796.1 1,076.8
Investing activities    
Capital expenditures (499.4) (383.5)
Acquisition of Whitewater (76.0) 0.0
Acquisition of Sapphire Sky, net of cash acquired of $0.3 (442.6) 0.0
Acquisition of Samson I, net of cash acquired of $5.2 (249.4) 0.0
Capital contributions to transmission affiliates (6.1) (21.1)
Proceeds from the sale of assets 4.6 9.7
Proceeds from the sale of investments held in rabbi trust 10.4 15.4
Insurance proceeds received for property damage 0.0 41.0
Other, net (9.4) 0.3
Net cash used in investing activities (1,267.9) (338.2)
Financing activities    
Exercise of stock options 0.9 11.8
Purchase of common stock (6.9) (23.4)
Dividends paid on common stock (246.1) (229.6)
Issuance of long-term debt 1,100.0 0.0
Retirement of long-term debt (35.2) (15.4)
Change in commercial paper (385.4) (447.9)
Payments for debt issuance costs (7.0) (0.8)
Other, net (2.7) (1.2)
Net cash provided by (used in) financing activities 417.6 (706.5)
Net change in cash, cash equivalents, and restricted cash (54.2) 32.1
Cash, cash equivalents, and restricted cash at beginning of period 182.2 87.5
Cash, cash equivalents, and restricted cash at end of period $ 128.0 $ 119.6